Estrogen blockers, also known as antiestrogens, are a class of pharmaceutical drugs used primarily in the treatment and prevention of breast cancer in hormone receptor-positive women. They work by blocking the effects of estrogen in the body. Some common estrogen blockers include tamoxifen, raloxifene, and aromatase inhibitors such as anastrozole, letrozole, and exemestane. These drugs are...
Market Overview:Estrogen blockers are medications that help inhibit the action of estrogen in the body. They are commonly used in the treatment of breast cancer, as well as hormone replacement therapy. These blockers work by binding to estrogen receptors, preventing estrogen from attaching to these receptors and stimulating cell growth. Some of the key players in the market include Pfizer Inc.,...
The global Estrogen Blockers Market is estimated to be valued at US$ 15.02 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Estrogen blockers are also known as anti-estrogens that help lower the level of estrogen in the body by binding to estrogen receptors and...
Key Takeaways Key players operating in the estrogen blockers market are Central Drug House, Croda International Plc., Emery Oleochemicals, Glentham Life Sciences Limited, Haihang Industry, Kunshan Odowell Co., Ltd, Matrica S.p.A, OQ Chemicals GmbH, Tokyo Chemical Industry Co., Ltd., and Zhengzhou Yibang Industry & Commerce Co., Ltd. Key players are focused on research and development...
The Estrogen Blockers Market involves the manufacturing and distribution of pharmaceutical compounds that selectively inhibit or block the effects of the hormone estrogen in the body. Estrogen blockers, also known as antiestrogens, work by binding to estrogen receptors in areas like the breasts or uterus to prevent estrogen from activating cell growth. Some key products in this market include...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian